Annual review of clinical research on lung transplantation of China in 2024
- VernacularTitle:2024年中国肺移植临床研究年度盘点
- Author:
Xiaohan JIN
1
;
Yixin SUN
1
;
Jier MA
1
;
Zengwei YU
2
;
Yaling LIU
2
;
Senlin HOU
2
;
Xiangyun ZHENG
2
;
Haoji YAN
2
;
Dong TIAN
2
,
3
Author Information
- Publication Type:AcademicSummary
- Keywords: Lung transplantation; Rejection; Infection; Acute kidney injury; Ischemia-reperfusion injury; Extracorporeal membrane oxygenation; Post-transplant diabetes mellitus; Donor shortage
- From: Organ Transplantation 2025;16(3):379-385
- CountryChina
- Language:Chinese
- Abstract: Lung transplantation is currently the only recognized effective treatment for end-stage lung disease and has improved the quality of life for patients. However, lung transplantation still faces many challenges, including rejection, infection, post-transplant acute kidney injury, post-transplant diabetes mellitus, ischemia-reperfusion injury and donor shortage, etc. Chinese lung transplantation scholars made a series of important progress in the field of clinical research in 2024, focusing on the study and solution of the above problems, and providing new ideas for lung transplantation surgery. This article systematically reviews the clinical research and technological innovation in the field of lung transplantation in 2024, summarizes the achievements of clinical research in the field of lung transplantation in China in 2024, and aims to providing new directions and strategies for future research.
